Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 210-540-0 | CAS number: 618-03-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data is from the safety assessment repot.
Data source
Reference
- Reference Type:
- secondary source
- Title:
- OPINION ON PHENYLBENZIMIDAZOLE SULFONIC ACID AND ITS SALTS
- Author:
- HEALTH AND CONSUMER PROTECTION DIRECTORATE GENERAL
- Year:
- 2 006
- Bibliographic source:
- OPINION ON PHENYLBENZIMIDAZOLE SULFONIC ACID AND ITS SALTS- SCCP/1056/06
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Principles of method if other than guideline:
- The skin sensitisation study was conducted on guinea pigs to determine its sensitisation potential of 2-phenyl-1H-benzimidazole-5-sulphonic acid.
- GLP compliance:
- not specified
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- not specified
Test material
- Reference substance name:
- Ensulizole
- IUPAC Name:
- Ensulizole
- Reference substance name:
- 2-phenyl-1H-benzimidazole-5-sulphonic acid
- EC Number:
- 248-502-0
- EC Name:
- 2-phenyl-1H-benzimidazole-5-sulphonic acid
- Cas Number:
- 27503-81-7
- IUPAC Name:
- 2-phenyl-1H-benzimidazole-5-sulfonic acid
- Test material form:
- solid
- Details on test material:
- - IUPAC name:Phenylbenzimidazole Sulfonic Acid
- Molecular formula: C13H10N2O3S
- Molecular weight: 274.299g/mol
- Substance type: organic
-Physical state: solid
Constituent 1
Constituent 2
- Specific details on test material used for the study:
- -IUPAC name: 2-phenyl-1H-benzimidazole-5-sulphonic acid
- Name of test material (as cited in study report): HR 92/103089
- Molecular formula: C13H10N2O3S
- Molecular weight: 274.299g/mol
- Substance type: organic
-Physical state: solid
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- not specified
- Details on test animals and environmental conditions:
- No data available.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- water
- Concentration / amount:
- 0.1ml Freund’s complete adjuvant in water
- Route:
- intradermal
- Vehicle:
- arachis oil
- Concentration / amount:
- 2-phenyl-1H-benzimidazole-5-sulphonic acid 1% w/v in arachis oil
- Day(s)/duration:
- Not specified
- Adequacy of induction:
- not specified
- Route:
- intradermal
- Vehicle:
- arachis oil
- Concentration / amount:
- Freund’s + 2-phenyl-1H-benzimidazole-5-sulphonic acid 1% w/v in arachis oil (1:1)
- Day(s)/duration:
- Not specified
- Adequacy of induction:
- not specified
- Route:
- other: Topical Application
- Vehicle:
- arachis oil
- Concentration / amount:
- •0.2 – 0.3 ml HR 92/103089 50% w/w in arachis oil
- Day(s)/duration:
- 48 hours
Challenge
- No.:
- #1
- Route:
- other: Epicutaneous
- Vehicle:
- arachis oil
- Concentration / amount:
- 0.1-0.2 ml 2-phenyl-1H-benzimidazole-5-sulphonic acid and 10% w/w in arachis oil
- Day(s)/duration:
- 21 days
- Adequacy of challenge:
- not specified
- No. of animals per dose:
- 20 test; 10 negative control
- Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 1
- Exposure period: 1 week
- Topical: 48 hours
- Test groups: 20
- Control group: 10
- Site: intradermal : three separate sites.
- Duration: Intradermal-1 week
Topical-48 hours
- Concentrations:
INTRADERMAL
•0.1ml Freund’s complete adjuvant in Water
•HR 92/103089 ((Phenylbenzimidazole Sulfonic Acid ) 1% w/v in arachis oil.
•Freund’s + HR 92/103089 1% w/v in arachis oil (1:1)
TOPICAL
After 1 week, a single topical application of 0.2 – 0.3 ml HR 92/103089 50% w/w in arachis oil under occlusion for 48 hours.
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: On day 21
- Exposure period: No Data Available
- Test groups: 20
- Control group: 10
- Site: No Data Available
- Concentrations: 0.1-0.2 ml HR 92/103089 25 and 10% w/w in arachis oil.
- Evaluation (hr after challenge): No data available. - Challenge controls:
- No Data Available
- Positive control substance(s):
- not specified
Results and discussion
In vivo (non-LLNA)
Results
- Reading:
- 1st reading
- Group:
- other: 20 test; 10 negative control
- Dose level:
- 0.1-0.2 ml 2-phenyl-1H-benzimidazole-5-sulphonic acid and 10% w/w in arachis oil
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No reactions were observed.
- Remarks on result:
- no indication of skin sensitisation
In vivo (LLNA)
- Cellular proliferation data / Observations:
- No reactions were observed.
Applicant's summary and conclusion
- Interpretation of results:
- other: not sensitising
- Conclusions:
- The substance 2-phenyl-1H-benzimidazole-5-sulphonic acid was observed to be not sensitising to guinea pigs skin.
- Executive summary:
The skin sensitisation study was conducted according to OECD guideline 406 on guinea pigs by Magnusson and Kligman test to determine its sensitisation potential of 2-phenyl-1H-benzimidazole-5-sulphonic acid. 20 test group and 10 negative control groups were used in this study. Intradermal injections of 0.1ml Freund’s complete adjuvant in water 2 -phenyl-1H-benzimidazole-5 -sulphonic acid 1% w/v in arachis oil, and Freund’s test material 1% w/v in arachis oil (1:1) into three separate sites. After 1 week, a single topical application of 0.2 – 0.3 ml test material 50% w/w in arachis oil under occlusion for 48 hours. On day 21 animals were challenged with0.1-0.2 ml 2-phenyl-1H-benzimidazole-5-sulphonic acid and 10% w/w in arachis oil. No reactions were observed. Thus, from the study it can be concluded that the substance 2-phenyl-1H-benzimidazole-5-sulphonic acid is not a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.